Sun Pharma gets FDA nod for Alzheimer’s generic

Friday, May 7th, 2010

MUMBAI, May 7 (Reuters) – India’s Sun Pharmaceuticals has received approval from the U.S. Food and Drug Administration to launch a generic version of Forest Laboratories’ Namenda tablets used to treat Alzheimer’s disease.

Originally posted here:
Sun Pharma gets FDA ... continue reading

Posted in Alzheimer's Disease | No Comments »